795
Views
0
CrossRef citations to date
0
Altmetric
Research Article

“Willingness to Pay”: The Value Attributed to Program Location by Pulmonary Rehabilitation Participants

ORCID Icon, , , , , , , , , , & show all
Pages 281-287 | Received 03 Mar 2021, Accepted 23 Apr 2021, Published online: 01 Jun 2021

References

  • Global Strategy for the Diagnosis, Management and Prevention of COPD [Internet]. Global Initiative for Chronic Obstructive Lung Disease; 2020 [cited 2020 Aug 31]. Available from: https://goldcopd.org/.
  • McCarthy B, Casey D, Devane D, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;2:CD003793.
  • Puhan M, Gimeno-Santos E, Cates C, et al. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2016;12:CD005305.
  • Camp P, Hernandez P, Bourbeau J, et al. Pulmonary rehabilitation in Canada: a report from the Canadian Thoracic Society COPD Clinical Assembly. Canadian Respir J. 2015;22(3):147–152.
  • Levack W, Weatherall M, Reeve J, et al. Uptake of pulmonary rehabilitation in New Zealand by people with COPD in 2009. NZ Med J. 2012;125:1–11.
  • Marks G, Reddel H, Guevara-Rattray E, et al. Monitoring pulmonary rehabilitation and long-term oxygen therapy for people with COPD in Australia: a discussion paper. Canberra (Australia): Australian Institute for Health and Welfare; 2013 [cited 2020 Aug 31]. Available from: https://nla.gov.au/nla.obj-778647592/view.
  • Desveaux L, Janaudis-Ferreira T, Goldstein R, et al. An international comparison of pulmonary rehabilitation: a systematic review. COPD. 2015;12(2):144–153.
  • Keating A, Lee A, Holland A. What prevents people with chronic obstructive pulmonary disease from attending pulmonary rehabilitation? A systematic review. Chron Respir Dis. 2011;8(2):89–99.
  • Coley C, Li Y, Medsger A, et al. Preferences for home vs hospital care among low-risk patients with community-acquired pneumonia. Arch Intern Med. 1996;156(14):1565–1571.
  • Marra C, Frighetto L, Goodfellow A, et al. Willingness to pay to assess patient preferences for therapy in a Canadian setting. BMC Health Serv Res. 2005;5(1):43.
  • Whitty J, Stewart S, Carrington M, et al. Patient preferences and willingness-to-pay for a home or clinic based program of chronic heart failure management: findings from WHICH? trial. PLoS One. 2013;8(3):e58347.
  • Bala M, Mauskopf J, Wood L. Willingness to pay as a measure of health benefits. Pharmacoeconomics. 1999;1:9–18.
  • Drummond MF, Sculpher MJ, Claxton K, et al. Methods for the economic evaluation of health care programmes. 4th ed. New York (NY): Oxford University Press; 2015.
  • Bergmo T, Wangberg S. Patients’ willingness to pay for electronic communication with their general practitioner. Eur J Health Econ. 2007;8(2):105–110.
  • Hammitt J. QALYs versus WTP. Risk Anal. 2002;22(5):985–1001. DOI:10.1111/1539-6924.00265
  • Bayoumi A. The measurement of contingent valuation for health economics. Pharmacoeconomics. 2004;22:691–700.
  • Stavem K. Association of willingness to pay with severity of chronic obstructive pulmonary disease, health status and other preference measures. Int J Tuberc Lung Dis. 2002;6(6):542–549.
  • Soeteman L, van Exel J, Bobinac A. The impact of the design of payment scales on the willingness to pay for health gains. Eur J Health Econ. 2017;18(6):743–760.
  • Kawata A, Kleinman L, Harding G, et al. Evaluation of patient preference and willingness to pay for attributes of maintenance medication for chronic obstructive pulmonary disease (COPD). Patient. 2014;7(4):413–426.
  • Chen Y, Ying Y, Chang K, et al. Study of patients’ willingness to pay for a cure of chronic obstructive pulmonary disease in Taiwan. IJERPH. 2016;13(3):273.
  • Holland AE, Mahal A, Hill C, et al. Patient preference and satisfaction in hospital-at-home and usual hospital care for COPD exacerbations: Results of a randomised controlled trial. BMC Pulm Med. 2013;13:57.
  • Holland AE, Mahal A, Hill C, et al. Home-based rehabilitation for COPD using minimal resources: a randomised, controlled equivalence trial. Thorax. 2017;72:57–65.
  • Spruit M, Singh S, Garvey C, et al. An official American Thoracic Society/European Respiratory Society Statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–1027.
  • Holland A, Spruit M, Troosters T, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428–1446.
  • Williams J, Singh S, Sewell L, et al. Development of a self-reported Chronic Respiratory Questionnaire (CRQ-SR). Thorax. 2001;56(12):954–959.
  • Hajiro T, Nishimura K, Tsukino M, et al. A comparison of the level of dyspnoea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest. 1999;116(6):1632–1637.
  • Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10(4):407–415.
  • Holland A, Hill C, Rasekaba T, et al. Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2010;91(2):221–225.
  • Schunemann HJ, Puhan M, Goldstein R, et al. Measurement properties and interpretability of the Chronic Respiratory Disease Questionnaire (CRQ). COPD. 2005;2(1):81–89.
  • Australian Bureau of Statistics. Census of Population and Housing: Socio-Economic Indexes for Areas (SEIFA). Canberra (Australia): Australian Government; 2011 [released 2013 Mar 28].
  • Mihaylova B, Briggs A, O’Hagan A, et al. Review of statistical methods for analysing healthcare resources and costs. Health Econ. 2011;20(8):897–916.
  • Field A. Discovering statistics using IBM SPSS statistics. 4th ed. London (UK): SAGE Publishing; 2014.
  • Sturm R. Economics and physical activity. A research agenda. Am J Prev Med. 2005;28(2):141–149.
  • Higgins A, Barnett J, Meads C, et al. Does convenience matter in health care delivery? A systematic review of convenience-based aspects of process utility. Value Health. 2014;17(8):877–887.
  • Goossens L, Utens C, Smeenk F, et al. Should I stay or should I go home? A latent class analysis of a discrete choice experiment on hospital-at-home. Value Health. 2014;17(5):588–596.
  • Utens C, Goossens L, van Schayck O, et al. Patient preference and satisfaction in hospital-at-home and usual hospital care for COPD exacerbations: Results of a randomised controlled trial. Int J Nursing Studies. 2013;50(11):1537–1549.
  • Burge AT, Holland AE, McDonald CF, et al. Home-based pulmonary rehabilitation for COPD using minimal resources: an economic analysis. Respirology. 2020;25:183–190.
  • Tinelli M, Ryan M, Bond C. What, who and when? Incorporating a discrete choice experiment into an economic evaluation. Health Econ Rev. 2016;6(1):31.
  • Rome A, Persson U, Ekdahl C, et al. Willingness to pay for health improvements of physical activity on prescription. Scand J Public Health. 2010;38(2):151–159.
  • Gyrd-Hansen D, Jensen M, Kjaer T. Framing the willingness-to-pay question: impact on response patterns and mean willingness to pay. Health Econ. 2014;23(5):550–563.
  • Donaldson C, Thomas R, Torgerson D. Validity of open-ended and payment scale approaches to eliciting willingness to pay. Appl Econ. 1997;29(1):79–84.
  • Whynes D, Philips Z, Frew E. Think of a number… any number? Health Econ. 2005;14(11):1191–1195. DOI:10.1002/hec.1001
  • Gyrd-Hansen D, Kjaer T. Disentangling WTP per QALY data: different analytical approaches, different answers. Health Econ. 2012;21(3):222–237.
  • O’Brien B, Viramontes JL. Willingness to pay: a valid and reliable measure of health state preference? Med Decis Making. 1994;14(3):289–297.
  • Persson U, Norinder A, Hjalte K, et al. The value of a statistical life in transport: findings from a new contingent valuation study in Sweden. J Risk Uncertainty. 2001;23(2):121–134.
  • Heng H, Lee A, Holland A. Repeating pulmonary rehabilitation: prevalence, predictors and outcomes. Respirology. 2014;19(7):999–1005.
  • Payne K, McAllister M, Davies L. Valuing the economic benefits of complex interventions: when maximising health is not sufficient. Health Econ. 2013;22(3):258–271.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.